Global Wet Macular Degeneration Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 114

Published Date: 01 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Wet macular degeneration is a chronic eye disorder that induces vague vision or a blind spot in the patient's visual field.

According to our (Global Info Research) latest study, the global Wet Macular Degeneration market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Wet Macular Degeneration market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Wet Macular Degeneration market size and forecasts, in consumption value ($ Million), 2018-2029
Global Wet Macular Degeneration market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Wet Macular Degeneration market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Wet Macular Degeneration market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Wet Macular Degeneration
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Wet Macular Degeneration market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Novartis AG and Bausch Health Companies Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Wet Macular Degeneration market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
by Drug
Lucentis
Eylea
Avastin
Others
by Route of Administration
Intravitreal
Intravenous

Market segment by Application
Hospitals
Clinics
Research Institutes
Academic Institutes

Market segment by players, this report covers
Pfizer Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
Novartis AG
Bausch Health Companies Inc.
Apellis Pharmaceuticals Inc.
GlaxoSmithKline plc
Ophthotech Corporation
Gilead Sciences, Inc.
Alcon
Genzyme Corporation
Boehringer Ingelheim GmbH
EyeGate Pharmaceuticals, Inc.
EyeCyte, Inc.
PanOptica Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Wet Macular Degeneration product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Wet Macular Degeneration, with revenue, gross margin and global market share of Wet Macular Degeneration from 2018 to 2023.
Chapter 3, the Wet Macular Degeneration competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Wet Macular Degeneration market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Wet Macular Degeneration.
Chapter 13, to describe Wet Macular Degeneration research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Wet Macular Degeneration
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Wet Macular Degeneration by Type
        1.3.1 Overview: Global Wet Macular Degeneration Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Wet Macular Degeneration Consumption Value Market Share by Type in 2022
        1.3.3 Lucentis
        1.3.4 Eylea
        1.3.5 Avastin
        1.3.6 Others
    1.4 Global Wet Macular Degeneration Market by Application
        1.4.1 Overview: Global Wet Macular Degeneration Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Research Institutes
        1.4.5 Academic Institutes
    1.5 Global Wet Macular Degeneration Market Size & Forecast
    1.6 Global Wet Macular Degeneration Market Size and Forecast by Region
        1.6.1 Global Wet Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Wet Macular Degeneration Market Size by Region, (2018-2029)
        1.6.3 North America Wet Macular Degeneration Market Size and Prospect (2018-2029)
        1.6.4 Europe Wet Macular Degeneration Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Wet Macular Degeneration Market Size and Prospect (2018-2029)
        1.6.6 South America Wet Macular Degeneration Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Wet Macular Degeneration Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Pfizer Inc.
        2.1.1 Pfizer Inc. Details
        2.1.2 Pfizer Inc. Major Business
        2.1.3 Pfizer Inc. Wet Macular Degeneration Product and Solutions
        2.1.4 Pfizer Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Inc. Recent Developments and Future Plans
    2.2 F. Hoffmann-La Roche AG
        2.2.1 F. Hoffmann-La Roche AG Details
        2.2.2 F. Hoffmann-La Roche AG Major Business
        2.2.3 F. Hoffmann-La Roche AG Wet Macular Degeneration Product and Solutions
        2.2.4 F. Hoffmann-La Roche AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
    2.3 Regeneron Pharmaceuticals, Inc.
        2.3.1 Regeneron Pharmaceuticals, Inc. Details
        2.3.2 Regeneron Pharmaceuticals, Inc. Major Business
        2.3.3 Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Product and Solutions
        2.3.4 Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Regeneron Pharmaceuticals, Inc. Recent Developments and Future Plans
    2.4 Novartis AG
        2.4.1 Novartis AG Details
        2.4.2 Novartis AG Major Business
        2.4.3 Novartis AG Wet Macular Degeneration Product and Solutions
        2.4.4 Novartis AG Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis AG Recent Developments and Future Plans
    2.5 Bausch Health Companies Inc.
        2.5.1 Bausch Health Companies Inc. Details
        2.5.2 Bausch Health Companies Inc. Major Business
        2.5.3 Bausch Health Companies Inc. Wet Macular Degeneration Product and Solutions
        2.5.4 Bausch Health Companies Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Bausch Health Companies Inc. Recent Developments and Future Plans
    2.6 Apellis Pharmaceuticals Inc.
        2.6.1 Apellis Pharmaceuticals Inc. Details
        2.6.2 Apellis Pharmaceuticals Inc. Major Business
        2.6.3 Apellis Pharmaceuticals Inc. Wet Macular Degeneration Product and Solutions
        2.6.4 Apellis Pharmaceuticals Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Apellis Pharmaceuticals Inc. Recent Developments and Future Plans
    2.7 GlaxoSmithKline plc
        2.7.1 GlaxoSmithKline plc Details
        2.7.2 GlaxoSmithKline plc Major Business
        2.7.3 GlaxoSmithKline plc Wet Macular Degeneration Product and Solutions
        2.7.4 GlaxoSmithKline plc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 GlaxoSmithKline plc Recent Developments and Future Plans
    2.8 Ophthotech Corporation
        2.8.1 Ophthotech Corporation Details
        2.8.2 Ophthotech Corporation Major Business
        2.8.3 Ophthotech Corporation Wet Macular Degeneration Product and Solutions
        2.8.4 Ophthotech Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Ophthotech Corporation Recent Developments and Future Plans
    2.9 Gilead Sciences, Inc.
        2.9.1 Gilead Sciences, Inc. Details
        2.9.2 Gilead Sciences, Inc. Major Business
        2.9.3 Gilead Sciences, Inc. Wet Macular Degeneration Product and Solutions
        2.9.4 Gilead Sciences, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Gilead Sciences, Inc. Recent Developments and Future Plans
    2.10 Alcon
        2.10.1 Alcon Details
        2.10.2 Alcon Major Business
        2.10.3 Alcon Wet Macular Degeneration Product and Solutions
        2.10.4 Alcon Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Alcon Recent Developments and Future Plans
    2.11 Genzyme Corporation
        2.11.1 Genzyme Corporation Details
        2.11.2 Genzyme Corporation Major Business
        2.11.3 Genzyme Corporation Wet Macular Degeneration Product and Solutions
        2.11.4 Genzyme Corporation Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Genzyme Corporation Recent Developments and Future Plans
    2.12 Boehringer Ingelheim GmbH
        2.12.1 Boehringer Ingelheim GmbH Details
        2.12.2 Boehringer Ingelheim GmbH Major Business
        2.12.3 Boehringer Ingelheim GmbH Wet Macular Degeneration Product and Solutions
        2.12.4 Boehringer Ingelheim GmbH Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
    2.13 EyeGate Pharmaceuticals, Inc.
        2.13.1 EyeGate Pharmaceuticals, Inc. Details
        2.13.2 EyeGate Pharmaceuticals, Inc. Major Business
        2.13.3 EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Product and Solutions
        2.13.4 EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 EyeGate Pharmaceuticals, Inc. Recent Developments and Future Plans
    2.14 EyeCyte, Inc.
        2.14.1 EyeCyte, Inc. Details
        2.14.2 EyeCyte, Inc. Major Business
        2.14.3 EyeCyte, Inc. Wet Macular Degeneration Product and Solutions
        2.14.4 EyeCyte, Inc. Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 EyeCyte, Inc. Recent Developments and Future Plans
    2.15 PanOptica Inc
        2.15.1 PanOptica Inc Details
        2.15.2 PanOptica Inc Major Business
        2.15.3 PanOptica Inc Wet Macular Degeneration Product and Solutions
        2.15.4 PanOptica Inc Wet Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 PanOptica Inc Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Wet Macular Degeneration Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Wet Macular Degeneration by Company Revenue
        3.2.2 Top 3 Wet Macular Degeneration Players Market Share in 2022
        3.2.3 Top 6 Wet Macular Degeneration Players Market Share in 2022
    3.3 Wet Macular Degeneration Market: Overall Company Footprint Analysis
        3.3.1 Wet Macular Degeneration Market: Region Footprint
        3.3.2 Wet Macular Degeneration Market: Company Product Type Footprint
        3.3.3 Wet Macular Degeneration Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Wet Macular Degeneration Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Wet Macular Degeneration Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Wet Macular Degeneration Consumption Value Market Share by Application (2018-2023)
    5.2 Global Wet Macular Degeneration Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Wet Macular Degeneration Consumption Value by Type (2018-2029)
    6.2 North America Wet Macular Degeneration Consumption Value by Application (2018-2029)
    6.3 North America Wet Macular Degeneration Market Size by Country
        6.3.1 North America Wet Macular Degeneration Consumption Value by Country (2018-2029)
        6.3.2 United States Wet Macular Degeneration Market Size and Forecast (2018-2029)
        6.3.3 Canada Wet Macular Degeneration Market Size and Forecast (2018-2029)
        6.3.4 Mexico Wet Macular Degeneration Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Wet Macular Degeneration Consumption Value by Type (2018-2029)
    7.2 Europe Wet Macular Degeneration Consumption Value by Application (2018-2029)
    7.3 Europe Wet Macular Degeneration Market Size by Country
        7.3.1 Europe Wet Macular Degeneration Consumption Value by Country (2018-2029)
        7.3.2 Germany Wet Macular Degeneration Market Size and Forecast (2018-2029)
        7.3.3 France Wet Macular Degeneration Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Wet Macular Degeneration Market Size and Forecast (2018-2029)
        7.3.5 Russia Wet Macular Degeneration Market Size and Forecast (2018-2029)
        7.3.6 Italy Wet Macular Degeneration Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Wet Macular Degeneration Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Wet Macular Degeneration Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Wet Macular Degeneration Market Size by Region
        8.3.1 Asia-Pacific Wet Macular Degeneration Consumption Value by Region (2018-2029)
        8.3.2 China Wet Macular Degeneration Market Size and Forecast (2018-2029)
        8.3.3 Japan Wet Macular Degeneration Market Size and Forecast (2018-2029)
        8.3.4 South Korea Wet Macular Degeneration Market Size and Forecast (2018-2029)
        8.3.5 India Wet Macular Degeneration Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Wet Macular Degeneration Market Size and Forecast (2018-2029)
        8.3.7 Australia Wet Macular Degeneration Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Wet Macular Degeneration Consumption Value by Type (2018-2029)
    9.2 South America Wet Macular Degeneration Consumption Value by Application (2018-2029)
    9.3 South America Wet Macular Degeneration Market Size by Country
        9.3.1 South America Wet Macular Degeneration Consumption Value by Country (2018-2029)
        9.3.2 Brazil Wet Macular Degeneration Market Size and Forecast (2018-2029)
        9.3.3 Argentina Wet Macular Degeneration Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Wet Macular Degeneration Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Wet Macular Degeneration Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Wet Macular Degeneration Market Size by Country
        10.3.1 Middle East & Africa Wet Macular Degeneration Consumption Value by Country (2018-2029)
        10.3.2 Turkey Wet Macular Degeneration Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Wet Macular Degeneration Market Size and Forecast (2018-2029)
        10.3.4 UAE Wet Macular Degeneration Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Wet Macular Degeneration Market Drivers
    11.2 Wet Macular Degeneration Market Restraints
    11.3 Wet Macular Degeneration Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Wet Macular Degeneration Industry Chain
    12.2 Wet Macular Degeneration Upstream Analysis
    12.3 Wet Macular Degeneration Midstream Analysis
    12.4 Wet Macular Degeneration Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Wet Macular Degeneration Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Wet Macular Degeneration Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Wet Macular Degeneration Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Wet Macular Degeneration Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
    Table 6. Pfizer Inc. Major Business
    Table 7. Pfizer Inc. Wet Macular Degeneration Product and Solutions
    Table 8. Pfizer Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Pfizer Inc. Recent Developments and Future Plans
    Table 10. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
    Table 11. F. Hoffmann-La Roche AG Major Business
    Table 12. F. Hoffmann-La Roche AG Wet Macular Degeneration Product and Solutions
    Table 13. F. Hoffmann-La Roche AG Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. F. Hoffmann-La Roche AG Recent Developments and Future Plans
    Table 15. Regeneron Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
    Table 16. Regeneron Pharmaceuticals, Inc. Major Business
    Table 17. Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Product and Solutions
    Table 18. Regeneron Pharmaceuticals, Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Regeneron Pharmaceuticals, Inc. Recent Developments and Future Plans
    Table 20. Novartis AG Company Information, Head Office, and Major Competitors
    Table 21. Novartis AG Major Business
    Table 22. Novartis AG Wet Macular Degeneration Product and Solutions
    Table 23. Novartis AG Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Novartis AG Recent Developments and Future Plans
    Table 25. Bausch Health Companies Inc. Company Information, Head Office, and Major Competitors
    Table 26. Bausch Health Companies Inc. Major Business
    Table 27. Bausch Health Companies Inc. Wet Macular Degeneration Product and Solutions
    Table 28. Bausch Health Companies Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Bausch Health Companies Inc. Recent Developments and Future Plans
    Table 30. Apellis Pharmaceuticals Inc. Company Information, Head Office, and Major Competitors
    Table 31. Apellis Pharmaceuticals Inc. Major Business
    Table 32. Apellis Pharmaceuticals Inc. Wet Macular Degeneration Product and Solutions
    Table 33. Apellis Pharmaceuticals Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Apellis Pharmaceuticals Inc. Recent Developments and Future Plans
    Table 35. GlaxoSmithKline plc Company Information, Head Office, and Major Competitors
    Table 36. GlaxoSmithKline plc Major Business
    Table 37. GlaxoSmithKline plc Wet Macular Degeneration Product and Solutions
    Table 38. GlaxoSmithKline plc Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. GlaxoSmithKline plc Recent Developments and Future Plans
    Table 40. Ophthotech Corporation Company Information, Head Office, and Major Competitors
    Table 41. Ophthotech Corporation Major Business
    Table 42. Ophthotech Corporation Wet Macular Degeneration Product and Solutions
    Table 43. Ophthotech Corporation Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Ophthotech Corporation Recent Developments and Future Plans
    Table 45. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
    Table 46. Gilead Sciences, Inc. Major Business
    Table 47. Gilead Sciences, Inc. Wet Macular Degeneration Product and Solutions
    Table 48. Gilead Sciences, Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Gilead Sciences, Inc. Recent Developments and Future Plans
    Table 50. Alcon Company Information, Head Office, and Major Competitors
    Table 51. Alcon Major Business
    Table 52. Alcon Wet Macular Degeneration Product and Solutions
    Table 53. Alcon Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Alcon Recent Developments and Future Plans
    Table 55. Genzyme Corporation Company Information, Head Office, and Major Competitors
    Table 56. Genzyme Corporation Major Business
    Table 57. Genzyme Corporation Wet Macular Degeneration Product and Solutions
    Table 58. Genzyme Corporation Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Genzyme Corporation Recent Developments and Future Plans
    Table 60. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
    Table 61. Boehringer Ingelheim GmbH Major Business
    Table 62. Boehringer Ingelheim GmbH Wet Macular Degeneration Product and Solutions
    Table 63. Boehringer Ingelheim GmbH Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Boehringer Ingelheim GmbH Recent Developments and Future Plans
    Table 65. EyeGate Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
    Table 66. EyeGate Pharmaceuticals, Inc. Major Business
    Table 67. EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Product and Solutions
    Table 68. EyeGate Pharmaceuticals, Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. EyeGate Pharmaceuticals, Inc. Recent Developments and Future Plans
    Table 70. EyeCyte, Inc. Company Information, Head Office, and Major Competitors
    Table 71. EyeCyte, Inc. Major Business
    Table 72. EyeCyte, Inc. Wet Macular Degeneration Product and Solutions
    Table 73. EyeCyte, Inc. Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. EyeCyte, Inc. Recent Developments and Future Plans
    Table 75. PanOptica Inc Company Information, Head Office, and Major Competitors
    Table 76. PanOptica Inc Major Business
    Table 77. PanOptica Inc Wet Macular Degeneration Product and Solutions
    Table 78. PanOptica Inc Wet Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. PanOptica Inc Recent Developments and Future Plans
    Table 80. Global Wet Macular Degeneration Revenue (USD Million) by Players (2018-2023)
    Table 81. Global Wet Macular Degeneration Revenue Share by Players (2018-2023)
    Table 82. Breakdown of Wet Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Wet Macular Degeneration, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key Wet Macular Degeneration Players
    Table 85. Wet Macular Degeneration Market: Company Product Type Footprint
    Table 86. Wet Macular Degeneration Market: Company Product Application Footprint
    Table 87. Wet Macular Degeneration New Market Entrants and Barriers to Market Entry
    Table 88. Wet Macular Degeneration Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Wet Macular Degeneration Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global Wet Macular Degeneration Consumption Value Share by Type (2018-2023)
    Table 91. Global Wet Macular Degeneration Consumption Value Forecast by Type (2024-2029)
    Table 92. Global Wet Macular Degeneration Consumption Value by Application (2018-2023)
    Table 93. Global Wet Macular Degeneration Consumption Value Forecast by Application (2024-2029)
    Table 94. North America Wet Macular Degeneration Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America Wet Macular Degeneration Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America Wet Macular Degeneration Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America Wet Macular Degeneration Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America Wet Macular Degeneration Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America Wet Macular Degeneration Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe Wet Macular Degeneration Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe Wet Macular Degeneration Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe Wet Macular Degeneration Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe Wet Macular Degeneration Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe Wet Macular Degeneration Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Wet Macular Degeneration Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Wet Macular Degeneration Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific Wet Macular Degeneration Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific Wet Macular Degeneration Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific Wet Macular Degeneration Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific Wet Macular Degeneration Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific Wet Macular Degeneration Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America Wet Macular Degeneration Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America Wet Macular Degeneration Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America Wet Macular Degeneration Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America Wet Macular Degeneration Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America Wet Macular Degeneration Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America Wet Macular Degeneration Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa Wet Macular Degeneration Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Wet Macular Degeneration Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa Wet Macular Degeneration Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa Wet Macular Degeneration Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Wet Macular Degeneration Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa Wet Macular Degeneration Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. Wet Macular Degeneration Raw Material
    Table 125. Key Suppliers of Wet Macular Degeneration Raw Materials
List of Figures
    Figure 1. Wet Macular Degeneration Picture
    Figure 2. Global Wet Macular Degeneration Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Wet Macular Degeneration Consumption Value Market Share by Type in 2022
    Figure 4. Lucentis
    Figure 5. Eylea
    Figure 6. Avastin
    Figure 7. Others
    Figure 8. Global Wet Macular Degeneration Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Wet Macular Degeneration Consumption Value Market Share by Application in 2022
    Figure 10. Hospitals Picture
    Figure 11. Clinics Picture
    Figure 12. Research Institutes Picture
    Figure 13. Academic Institutes Picture
    Figure 14. Global Wet Macular Degeneration Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Wet Macular Degeneration Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Wet Macular Degeneration Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Wet Macular Degeneration Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Wet Macular Degeneration Consumption Value Market Share by Region in 2022
    Figure 19. North America Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Wet Macular Degeneration Revenue Share by Players in 2022
    Figure 25. Wet Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Wet Macular Degeneration Market Share in 2022
    Figure 27. Global Top 6 Players Wet Macular Degeneration Market Share in 2022
    Figure 28. Global Wet Macular Degeneration Consumption Value Share by Type (2018-2023)
    Figure 29. Global Wet Macular Degeneration Market Share Forecast by Type (2024-2029)
    Figure 30. Global Wet Macular Degeneration Consumption Value Share by Application (2018-2023)
    Figure 31. Global Wet Macular Degeneration Market Share Forecast by Application (2024-2029)
    Figure 32. North America Wet Macular Degeneration Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Wet Macular Degeneration Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Wet Macular Degeneration Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Wet Macular Degeneration Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Wet Macular Degeneration Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Wet Macular Degeneration Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Wet Macular Degeneration Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Wet Macular Degeneration Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Wet Macular Degeneration Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Wet Macular Degeneration Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Wet Macular Degeneration Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Wet Macular Degeneration Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Wet Macular Degeneration Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Wet Macular Degeneration Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Wet Macular Degeneration Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Wet Macular Degeneration Consumption Value (2018-2029) & (USD Million)
    Figure 66. Wet Macular Degeneration Market Drivers
    Figure 67. Wet Macular Degeneration Market Restraints
    Figure 68. Wet Macular Degeneration Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Wet Macular Degeneration in 2022
    Figure 71. Manufacturing Process Analysis of Wet Macular Degeneration
    Figure 72. Wet Macular Degeneration Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
Novartis AG
Bausch Health Companies Inc.
Apellis Pharmaceuticals Inc.
GlaxoSmithKline plc
Ophthotech Corporation
Gilead Sciences, Inc.
Alcon
Genzyme Corporation
Boehringer Ingelheim GmbH
EyeGate Pharmaceuticals, Inc.
EyeCyte, Inc.
PanOptica Inc

Related Reports

Global Wet Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Wet Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Wet Macular Degeneration market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Wet Macular Degeneration Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Wet Macular Degeneration Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 15 Jan 2022

date Pharma & Healthcare

Global Wet Macular Degeneration Supply, Demand and Key Producers, 2023-2029

Global Wet Macular Degeneration Supply, Demand and Key Producers, 2023-2029

date 01 Feb 2023

date Pharma & Healthcare

The global Wet Macular Degeneration market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Wet Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Wet Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Wet Macular Degeneration market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

wet macular degeneration

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>